title: Immunocytochemical assessment of sigma-1 receptor and human sterol isomerase in breast cancer and their relationship with a series of prognostic factors.
abstract: The purpose of this study was to immunocytochemically investigate two new markers, the sigma-1 receptor and the human sterol isomerase (hSI), in comparison with a series of clinicopathological and immunocytochemical prognostic factors in a trial including 95 patients with operable primary breast cancers. Our results showed no statistically significant relationship between these two markers and the age of the patients, their menopausal status, the tumour size and its histological grade, the nodal status and the expression of the Ki-67 proliferative marker. However, we evidenced a close correlation between the sigma-1 receptor expression and the hormonal receptor positivity (P = 0.008), essentially due to a link with the progesterone receptor status (P = 0.01). By contrast there was an inverse relationship between hSI expression and the oestrogen receptor and/or progesterone receptor positivity (P = 0.098). A significant relationship was shown between both the sigma-1 receptor, hSI expressions and Bcl2 expression, with P= 0.017 and 0.035 respectively. We also assessed whether the expression of the sigma-1 receptor or hSI might be linked with disease-free survival (DFS) and found that the presence of hSI and the absence of sigma-1 receptor expression were associated with a poorer disease-free survival (P= 0.007). Altogether these results suggest that in primary breast carcinomas in association with the evaluation of the steroid receptor status, the sigma-1 receptor and hSI may be interesting new markers useful to identify those patients who might be able to benefit from an adjuvant therapy.
authors.affiliation: Department of Pathology, Montpellier Cancer Institute, France.
authors.forename: J
authors.initials: J
authors.lastname: Simony-Lafontaine
authors.forename: M
authors.initials: M
authors.lastname: Esslimani
authors.forename: E
authors.initials: E
authors.lastname: Bribes
authors.forename: S
authors.initials: S
authors.lastname: Gourgou
authors.forename: N
authors.initials: N
authors.lastname: Lequeux
authors.forename: R
authors.initials: R
authors.lastname: Lavail
authors.forename: J
authors.initials: J
authors.lastname: Grenier
authors.forename: A
authors.initials: A
authors.lastname: Kramar
authors.forename: P
authors.initials: P
authors.lastname: Casellas
mesh_terms: D000328:Adult; D000367:Age Factors; D000368:Aged; D014408:Biomarkers, Tumor / Q000378:metabolism; D001943:Breast Neoplasms / Q000378:metabolism* / Q000473:pathology; D002352:Carrier Proteins / Q000378:metabolism*; D006801:Humans; D007150:Immunohistochemistry; D008593:Menopause; D008875:Middle Aged; D011379:Prognosis; D017480:Receptors, sigma / Q000378:metabolism*; D013251:Steroid Isomerases; D000097605:Sigma-1 Receptor
chemical_list: D014408:Biomarkers, Tumor; D002352:Carrier Proteins; D017480:Receptors, sigma; D013251:Steroid Isomerases; D000097605:Sigma-1 Receptor; C090445:EBP protein, human